Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Syneos Health, Inc. - Class A Common Stock (NQ: SYNH )

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Sep 27, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Syneos Health, Inc. - Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >
SYNH INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Files Class Action Lawsuit Against Syneos Health, Inc. and Announces Opportunity for Investors with Substantial Losses to Lead the Syneos Class Action Lawsuit
From Robbins Geller Rudman & Dowd LLP
Via Business Wire
BioMedNewsBreaks – FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) Reports Arbitration Panel Finding in Syneos Health (NASDAQ: SYNH) Proceeding
Via Investor Brand Network
Exposures Product Safety
Syneos Health Appoints Hillary Bochniak as Chief Human Resources Officer
Human Resources Leader with Nearly 30 Years of Experience and Commitment to Professional Services Environment 
From Syneos Health, Inc.
Via GlobeNewswire
8 Analysts Have This to Say About Syneos Health
Via Benzinga
Syneos Health Target Price Raised Amid $7.1B Acquisition News: Analyst Provides Insight
Via Benzinga
Syneos Health and uMotif Partner to Deliver Patient-centric eClinical Platform
Integrated eCOA & ePRO Solution Taps Company’s Decentralized Capabilities and Technology Expertise 
From Syneos Health, Inc.
Via GlobeNewswire
Syneos Health Appoints Batisha Anson to Global Head, Patient Diversity and Health Equity
Newly Created Role Demonstrates Commitment to Improve Diversity in Clinical Trials and Commercialization Across Organization 
From Syneos Health, Inc.
Via GlobeNewswire
Syneos Health Leaders Recognized by HBA
Healthcare Businesswomen’s Association Spotlights Jennifer Sozio and Caitlin Purinai for Biopharma Industry Impact 
From Syneos Health, Inc.
Via GlobeNewswire
Syneos To Be Acquired By Private Investment Consortium For $7.1B, Q1 Earnings Beat Expectations
Via Benzinga
Syneos Health: Q1 Earnings Insights
Via Benzinga
Syneos Health Leaders Recognized as PM360 2023 ELITE Award Recipients
Company Executives Honored for Notable Biopharmaceutical Industry Impact 
From Syneos Health, Inc.
Via GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For May 11, 2023
Via Benzinga
SYNEOS HEALTH INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Syneos Health, Inc. - SYNH
From Kahn Swick & Foti, LLC
Via Business Wire
7 Analysts Have This to Say About Syneos Health
Via Benzinga
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Syneos Health, Inc. (Nasdaq – SYNH), Franchise Group, Inc. (Nasdaq – FRG), CTI BioPharma Corp. (Nasdaq – CTIC), Ruth’s Inc. (Nasdaq – RUTH)
From Brodsky & Smith LLC
Via GlobeNewswire
Upstart (UPST) Stock Skyrockets 32% on Funding News
Upstart (UPST) stock is heading higher on Wednesday after the AI investing company secured an additional $2 million in funding. 
Via InvestorPlace
SYNH Stock Alert: The $7 Billion Reason Syneos Health Is Up Today
Syneos Health (SYNH) stock is on the rise Wednesday as investors react to news of a $7.1 billion acquisition deal with a group of investors. 
Via InvestorPlace
SYNH STOCK ALERT: Halper Sadeh LLC Is Investigating Whether the Sale of Syneos Health, Inc. Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
Syneos Health Reports First Quarter 2023 Results
From Syneos Health, Inc.
Via GlobeNewswire
Syneos Health to be Acquired by a Private Investment Consortium for Approximately $7.1 Billion
From Syneos Health, Inc.
Via GlobeNewswire
Syneos Health Close To Being Acquired For $7B - Elliott, Patient Square and Veritas Investment Consortium Lead Deal
A group of investors, including Elliott Investment Management, Patient Square Capital, and Veritas Capital, is close to acquiring Syneos Health Inc (NASDAQ: SYNH) for more than $7 billion, including... 
Via Benzinga
Syneos Health Appoints Michael Bonello as Chief Financial Officer
Finance Leader with 30+ Years of Experience, Including 15 Years in Clinical Research Industry 
From Syneos Health, Inc.
Via GlobeNewswire
Syneos Health Schedules First Quarter 2023 Earnings Call for Wednesday, May 10th, 2023
From Syneos Health, Inc.
Via GlobeNewswire
Why Tupperware Brands Shares Are Trading Lower By Over 40%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Gainers PLx Pharma Inc. (NASDAQ: PLXP) gained 128.2% to $0.2399 after dropping over 13% on Thursday. 
Via Benzinga
Micron Technology, Greenbrier Companies And Other Big Stocks Moving Higher On Monday
U.S. stocks traded lower, with the Nasdaq Composite falling over 100 points on Monday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Syneos Health Wins 2023 ViE Award
Company Recognized for Positive Vaccine Expertise Contributions 
From Syneos Health, Inc.
Via GlobeNewswire
Syneos Health Names Jeanine O’Kane as Communications President
From Syneos Health, Inc.
Via GlobeNewswire
Syneos Health Launches Medical Affairs Digital Amplifier
Program Drives Digital and Omnichannel Engagement for Medical Science Liaison Teams & Medical Conferences 
From Syneos Health, Inc.
Via GlobeNewswire
Syneos Health and KX Partner to Pioneer Data-Driven Transformation in Biopharmaceutical Asset Development
Collaboration Will Leverage Data Analytics and AI to Accelerate Clinical Trial Execution 
From Syneos Health, Inc.
Via GlobeNewswire
Syneos Health Collaborates with Microsoft to Accelerate AI Across the Clinical to Commercial Continuum
Collaboration Leverages AI-ready Technology to Speed Asset Development and Optimize Performance 
From Syneos Health, Inc.
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.